Blood pressure medication recalled over labeling error

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

A drug manufacturer is recalling bottles of a blood pressure medication after a mislabeled bottle was found to contain a different medication.

Accord Healthcare Inc. is voluntarily recalling one lot of Hydrochlorothiazide Tablets, 12.5 mg.

A 100-count bottle of Hydrochlorothiazide Tablets was found at a pharmacy containing 100 Spironolactone Tablets, the U.S. Food and Drug Administration said.

“Based on findings of both preliminary and interim investigations carried out at the manufacturing site, Accord believes that no other lots of Hydrochlorothiazide Tablets are involved in this mix-up,” the FDA said.

Hydrochlorothiazide Tablets are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side.

If you have these drugs, the FDA asks you to please return to your pharmacy or healthcare provider for confirmation.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.